Arteriosclerosis, Vol 9, 176-183, Copyright © 1989 by American Heart Association

ARTICLES

Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits. Differences in intimal clearance explained by size differences

BG Nordestgaard and DB Zilversmit
Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853.

Arterial intimal clearances of low density lipoproteins (LDL) from diabetic cholesterol-fed rabbits (D-LDL) and LDL from nondiabetic cholesterol-fed rabbits (N-LDL) were compared. In six experiments, D- LDL and N-LDL were isolated from a diabetic and a nondiabetic rabbit, were iodinated with 125I and 131I, respectively, were mixed, and were reinjected into the same two rabbits as well as into a normal rabbit. Fractional catabolic rates for D-LDL and N-LDL in normal rabbits were 0.065 and 0.074 h-1 (p less than 0.05), respectively. For five of the six pairs of LDL, the D-LDL was smaller than N-LDL as determined by gel filtration. The arterial permeability to N-LDL, when normalized for differences in arterial cholesterol content, did not appear to differ between diabetic and nondiabetic rabbits. The relative arterial intimal clearance (D-LDL/N-LDL) in arteries from diabetic and nondiabetic rabbits was inversely related to the relative molecular weight (D-LDL/N- LDL). For example, when the molecular weight of D-LDL was as low as 60% of that of N-LDL (i.e., the diameter of D-LDL was reduced 16%), the intimal clearance of D-LDL was 40% larger than that of N-LDL. When, on the other hand, molecular weights and diameters of the two LDL were similar, the intimal clearance was also quite similar. These results suggest that arterial intimal clearance of LDL from diabetic and nondiabetic cholesterol-fed rabbits is comparable unless the two types of LDL have a different size.

This article has been cited by other articles:

				R. S. Rosenson, D. A. Wolff, A. L. Huskin, I. B. Helenowski, and A. W. Rademaker Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome Diabetes Care, August 1, 2007; 30(8): 1945 - 1951. [Abstract] [Full Text] [PDF]

				J. Benton, A. Powers, L. Eiselein, R. Fitch, D. Wilson, A. C. Villablanca, and J. C. Rutledge Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R723 - R730. [Abstract] [Full Text] [PDF]

				S. Kathiresan, J. D. Otvos, L. M. Sullivan, M. J. Keyes, E. J. Schaefer, P. W.F. Wilson, R. B. D'Agostino, R. S. Vasan, and S. J. Robins Increased Small Low-Density Lipoprotein Particle Number: A Prominent Feature of the Metabolic Syndrome in the Framingham Heart Study Circulation, January 3, 2006; 113(1): 20 - 29. [Abstract] [Full Text] [PDF]

				J. S. Jensen, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and B. G. Nordestgaard Increased Transvascular Lipoprotein Transport in Diabetes: Association with Albuminuria and Systolic Hypertension J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4441 - 4445. [Abstract] [Full Text] [PDF]

				K. Kornerup, B. G. Nordestgaard, T. K. Jensen, B. Feldt-Rasmussen, J. P. Eiberg, K. S. Jensen, and J. S. Jensen Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis Cardiovasc Res, November 1, 2004; 64(2): 337 - 345. [Abstract] [Full Text] [PDF]

				J. S. Jensen, B. Feldt-Rasmussen, K. S. Jensen, P. Clausen, H. Scharling, and B. G. Nordestgaard Transendothelial lipoprotein exchange and microalbuminuria Cardiovasc Res, July 1, 2004; 63(1): 149 - 154. [Abstract] [Full Text] [PDF]

				F. M. Sacks and H. Campos Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4525 - 4532. [Full Text] [PDF]

				S. D. Proctor and J. C.L. Mamo Intimal Retention of Cholesterol Derived From Apolipoprotein B100- and Apolipoprotein B48-Containing Lipoproteins in Carotid Arteries of Watanabe Heritable Hyperlipidemic Rabbits Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1595 - 1600. [Abstract] [Full Text] [PDF]

				K. Kornerup, B. G. Nordestgaard, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and J. S. Jensen Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2): A Noninvasive In Vivo Isotope Technique Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1168 - 1174. [Abstract] [Full Text] [PDF]

				A. D. Sniderman, T. Scantlebury, and K. Cianflone Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus Ann Intern Med, September 18, 2001; 135(6): 447 - 459. [Abstract] [Full Text] [PDF]

				A. D. Sniderman, J. Bergeron, and J. Frohlich Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial Can. Med. Assoc. J., January 1, 2001; 164(1): 44 - 47. [Full Text] [PDF]

				R. A. P. Skyrme-Jones, R. C. O'Brien, M. Luo, and I. T. Meredith Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes J. Am. Coll. Cardiol., February 1, 2000; 35(2): 292 - 299. [Abstract] [Full Text] [PDF]

				N. F. Galeano, M. Al-Haideri, F. Keyserman, S. C. Rumsey, and R. J. Deckelbaum Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity J. Lipid Res., June 1, 1998; 39(6): 1263 - 1273. [Abstract] [Full Text]

				P. Reaven, S. Merat, F. Casanada, M. Sutphin, and W. Palinski Effect of Streptozotocin-Induced Hyperglycemia on Lipid Profiles, Formation of Advanced Glycation Endproducts in Lesions, and Extent of Atherosclerosis in LDL Receptor-Deficient Mice Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2250 - 2256. [Abstract] [Full Text]

				L. B. Nielsen, M. L.M. Gronholdt, T. V. Schroeder, S. Stender, and B. G. Nordestgaard In Vivo Transfer of Lipoprotein(a) Into Human Atherosclerotic Carotid Arterial Intima Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 905 - 911. [Abstract] [Full Text]

				P. Reaven, B. Grasse, and J. Barnett Effect of Antioxidants Alone and in Combination With Monounsaturated Fatty Acid–Enriched Diets on Lipoprotein Oxidation Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1465 - 1472. [Abstract] [Full Text]

				K. Juul, L. B. Nielsen, K. Munkholm, S. Stender, and B. G. Nordestgaard Oxidation of Plasma Low-Density Lipoprotein Accelerates Its Accumulation and Degradation in the Arterial Wall In Vivo Circulation, October 1, 1996; 94(7): 1698 - 1704. [Abstract] [Full Text]

				L. B. Nielsen, B. G. Nordestgaard, S. Stender, A. Niendorf, and K. Kjeldsen Transfer of Lipoprotein(a) and LDL Into Aortic Intima in Normal and in Cholesterol-Fed Rabbits Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1492 - 1502. [Abstract] [Full Text]

				B. G. Nordestgaard, R. Wootton, and B. Lewis Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo : Molecular Size as a Determinant of Fractional Loss From the Intima–Inner Media Arterioscler Thromb Vasc Biol, April 1, 1995; 15(4): 534 - 542. [Abstract] [Full Text]